(HCAT) Health Catalyst - Ratings and Ratios

Health Catalyst, Inc. (NASDAQ:HCAT) is a leading provider of data and analytics solutions for healthcare organizations in the United States. The company operates through two primary segments: Technology and Professional Services. Its core offering includes a data operating system (DOS) platform, which integrates and organizes data from disparate systems, enabling healthcare providers to make data-driven decisions. Additionally, it provides analytics applications tailored for clinical and quality improvement, population health management, and financial and operational optimization. The company also offers a range of services, including data governance, quality improvement strategies, cost accounting, and population health strategies, leveraging its expertise in healthcare data and analytics. Founded in 2008 and headquartered in South Jordan, Utah, Health Catalyst has established itself as a key player in the healthcare technology sector.

Based on the provided data, Health Catalysts stock is currently trading at $4.67, below its 20-day SMA of $5.35 and 50-day SMA of $6.08, indicating bearish momentum. The 200-day SMA of $7.07 suggests a longer-term downtrend. With an ATR of 0.37, volatility is moderate. Fundamentally, the companys market cap of $327.97M, P/B ratio of 0.95, and P/S ratio of 1.09 indicate undervaluation relative to its peers. However, the negative RoE of -22.29% reflects profitability challenges. Over the next three months, HCAT is likely to face resistance at $5.35 (20-day SMA) and $6.08 (50-day SMA), with support potentially forming near $4.00. Upside momentum could resume if the stock regains its 50-day SMA, while a breach below $4.00 may signal further downside. The forward P/E of 24.15 suggests investor optimism about future earnings growth, but execution will be critical to justify valuations.